RRM2 overexpression was significantly associated with invasion depth and differentiation, and clinical tissue specimens also showed that the expression levels of RRM2 may be associated with tumor stage, which was shown in Ai-Guo Lu et al.'s study (Lu et al., 2012). The gene discussed is RRM2; the disease is neoplasm.